About
Leadership
Community Outreach
Careers
Contact Us
Technology
Lenti-VEX™ Delivery Platform
Lenti-VO™ Delivery Platform
Manufacturing
Publications
Pipeline & Clinical Trials
D-Fi Gene Therapy for Dystrophic Epidermolysis Bullosa (DEB)
LV-FAH Gene Therapy
for Hereditary Tyrosinemia Type 1 (HT1)
Clinical Trials
Patients & Families
Epidermolysis Bullosa (EB)
Tyrosinemia
Newsroom
Press Releases
Events & Presentations
Media Coverage
Contact Us
Toggle navigation
Events & Presentations
Newsroom
Hybrid Conference | Washington, DC
May 16-19, 2022
American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Hybrid Conference
